Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript

Page 2 of 2

Jason Butler: Great. Thanks for taking the question.

Operator: Thank you. There are no further questions at this time. I’d now like to turn the call back over to Mr. Chee for final closing comments.

Conley Chee: Thank you, operator, and thank you, everyone, for joining us today. We are looking forward to an exciting and productive year ahead, and appreciate your continued support to Syros. Please reach out to us, if you have any further questions and have a great day.

Operator: Thank you, sir. Ladies and gentlemen, this concludes your conference call for today. We thank you for participating, and ask that you please disconnect your lines. Have a lovely day.

Follow Syros Pharmaceuticals Inc.

Page 2 of 2